MedPath

Comparison Of Mefenamic acid Capsules and Ginger and Exercise On Pain During Mensturatio

Phase 3
Conditions
primary Dysmenorrhea.
primary Dysmenorrhea
Registration Number
IRCT201203118822N2
Lead Sponsor
Mazandaran University Of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
61
Inclusion Criteria

individuals who have primary dysmenorrhea, the pain that affects their daily activities participated in study.The pain is moderate to severe; pain during the menstrual cycle and in more than 50% for at least one day exist. Exclusion criteria: having a menstrual cycle irregular (usually outside the range of 21 to 35 days); use of IUD or receiving OCP; history of exercise regularly (3 times a week for 30 to 45 minutes) and having dysmenorrhea secondary.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduce the severity of dysmenorrhea. Timepoint: Before intervention then twice every month. Method of measurement: VAS scale.
Secondary Outcome Measures
NameTimeMethod
Drug side effects. Timepoint: Before starting intervention and then at intervals of twice a month. Method of measurement: VAS scale.;Reduce the amount of bleeding. Timepoint: Before starting intervention and then at intervals of twice a month. Method of measurement: VAS scale.;Duration of pain. Timepoint: Before starting intervention and then at intervals of twice a month. Method of measurement: VAS scale.
© Copyright 2025. All Rights Reserved by MedPath